Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pancreatic Volume in Type 2 Diabetes Treatments
NCT02244164Terminated
- Sponsor
- Erasmus Hospital
- Start
- Oct 2014
- Primary completion
- Feb 2023
- Countries
- 1
01
Overview
Open-label trial in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Erasmus Hospital. Primary endpoint: Volumetric measurement of the pancreas at 1 year. Started Oct 2014; status: terminated.
02
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02244164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02244164.